|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.686
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.349
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.338
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.335
|
|
|
|
long chain fatty acid import
|
GO:0044539 |
2 |
0.299
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.276
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.235
|
|
|
|
satellite cell activation involved in skeletal muscle regeneration
|
GO:0014901 |
3 |
0.227
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.197
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.191
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.189
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.188
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.188
|
|
|
|
establishment of blood nerve barrier
|
GO:0008065 |
3 |
0.184
|
|
|
|
regulation of phosphatidylcholine biosynthetic process
|
GO:2001245 |
2 |
0.181
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.181
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.180
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.162
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.161
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.160
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.159
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.143
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.141
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.138
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.135
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.124
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.124
|
|
|
|
regulation of renin secretion into blood stream
|
GO:1900133 |
4 |
0.123
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.116
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.113
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.113
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.111
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.108
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.106
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.105
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.105
|
|
|
|
foramen ovale closure
|
GO:0035922 |
1 |
0.104
|
|
|
|
retinoic acid metabolic process
|
GO:0042573 |
12 |
0.104
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.102
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.101
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.101
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.101
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.101
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.100
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.100
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.099
|
|
|
|
positive regulation of cell growth
|
GO:0030307 |
33 |
0.099
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.099
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.098
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.093
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.092
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.092
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.092
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.091
|
|
|
|
intermediate filament cytoskeleton organization
|
GO:0045104 |
26 |
0.089
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.088
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.087
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.086
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.085
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.084
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.081
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.080
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.079
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.078
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.077
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.077
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.077
|
|
|
|
protein activation cascade
|
GO:0072376 |
19 |
0.076
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.076
|
|
|
|
retinoid metabolic process
|
GO:0001523 |
24 |
0.075
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.075
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.074
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.074
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.073
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.072
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.071
|
|
|
|
av node cell to bundle of his cell communication
|
GO:0086067 |
2 |
0.071
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.069
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.068
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.068
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.068
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.068
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.067
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.067
|
|
|
|
keratinocyte differentiation
|
GO:0030216 |
48 |
0.067
|
|
|
|
cell communication by electrical coupling involved in cardiac conduction
|
GO:0086064 |
2 |
0.067
|
|
|
|
tissue regeneration
|
GO:0042246 |
22 |
0.066
|
|
|
|
regulation of keratinocyte differentiation
|
GO:0045616 |
11 |
0.066
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.065
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.065
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.065
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.063
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.063
|
|
|
|
sa node cell action potential
|
GO:0086015 |
4 |
0.062
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.062
|
|
|
|
regulation of membrane depolarization during action potential
|
GO:0098902 |
1 |
0.062
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.061
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.061
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.061
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.060
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.060
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.060
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.059
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.059
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.059
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.059
|
|
|
|
regulation of satellite cell activation involved in skeletal muscle regeneration
|
GO:0014717 |
3 |
0.059
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.058
|
|
|
|
atrial ventricular junction remodeling
|
GO:0003294 |
2 |
0.058
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.058
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.057
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.057
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.056
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.056
|
|
|
|
fibrinolysis
|
GO:0042730 |
3 |
0.056
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.056
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.056
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.055
|
|
|
|
intermediate filament based process
|
GO:0045103 |
27 |
0.055
|
|
|
|
diterpenoid metabolic process
|
GO:0016101 |
24 |
0.055
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.055
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.054
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.054
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.054
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.053
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.053
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.053
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.052
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.052
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.052
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.052
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.052
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.052
|
|
|
|
septum primum development
|
GO:0003284 |
4 |
0.051
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.051
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.051
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.050
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.050
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.050
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.050
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.050
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.050
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.050
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.050
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.050
|
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.050
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.049
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.048
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.048
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.048
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.048
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.048
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.048
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.047
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.047
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.047
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.046
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.046
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.046
|
|
|
|
intermediate filament organization
|
GO:0045109 |
15 |
0.045
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.045
|
|
|
|
female genitalia morphogenesis
|
GO:0048807 |
3 |
0.045
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.045
|
|
|
|
response to vitamin a
|
GO:0033189 |
1 |
0.044
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.044
|
|
|
|
water homeostasis
|
GO:0030104 |
27 |
0.043
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.043
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.043
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.042
|
|
|
|
vasodilation
|
GO:0042311 |
28 |
0.042
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.042
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.042
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.042
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.042
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.042
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.041
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.041
|
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.041
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.041
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.041
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.041
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.041
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.040
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.040
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.040
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.040
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.040
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.039
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.039
|
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.039
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.039
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.039
|
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.039
|
|
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.039
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.038
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.038
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.038
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.038
|
|
|
|
regulation of bone mineralization
|
GO:0030500 |
31 |
0.038
|
|
|
|
ventricular cardiac muscle cell action potential
|
GO:0086005 |
4 |
0.038
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.038
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.038
|
|
|
|
regulation of epidermis development
|
GO:0045682 |
33 |
0.038
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.038
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.037
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.037
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.037
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.037
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.037
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.037
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.037
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.036
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
29 |
0.036
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.036
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.036
|
|
|
|
milk ejection
|
GO:0060156 |
1 |
0.036
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.036
|
|
|
|
terpenoid metabolic process
|
GO:0006721 |
25 |
0.036
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.036
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.036
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.036
|
|
|
|
regulation of tissue remodeling
|
GO:0034103 |
38 |
0.036
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.035
|
|
|
|
regulation of phospholipid biosynthetic process
|
GO:0071071 |
3 |
0.035
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.035
|
|
|
|
regulation of membrane depolarization
|
GO:0003254 |
11 |
0.035
|
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
7 |
0.035
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.035
|
|
|
|
regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014066 |
30 |
0.035
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.035
|
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
52 |
0.035
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.035
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.035
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.035
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.034
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.034
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.034
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.034
|
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.034
|
|
|
|
isoprenoid metabolic process
|
GO:0006720 |
29 |
0.034
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.034
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.034
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.033
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.033
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.033
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.033
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.033
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.033
|
|
|
|
regulation of ventricular cardiac muscle cell membrane depolarization
|
GO:0060373 |
2 |
0.033
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.033
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.033
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.033
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.033
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.032
|
|
|
|
tube lumen cavitation
|
GO:0060605 |
5 |
0.032
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.032
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.032
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.032
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.032
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.031
|
|
|
|
ventricular cardiac myofibril assembly
|
GO:0055005 |
3 |
0.031
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.031
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.031
|
|
|
|
positive regulation of vasoconstriction
|
GO:0045907 |
4 |
0.031
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.031
|
|
|
|
monocarboxylic acid catabolic process
|
GO:0072329 |
27 |
0.031
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.031
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.031
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.031
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.031
|
|
|
|
astrocyte differentiation
|
GO:0048708 |
43 |
0.030
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.030
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.030
|
|
|
|
negative regulation of gastrulation
|
GO:2000542 |
3 |
0.030
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.030
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.030
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.030
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.030
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.030
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.030
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.030
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.029
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.029
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.029
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.029
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.029
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.029
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.029
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.029
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.029
|
|
|
|
regulation of membrane depolarization during cardiac muscle cell action potential
|
GO:1900825 |
1 |
0.028
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.028
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.028
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.028
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.028
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.028
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.028
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.028
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.028
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.028
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.027
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.027
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.027
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.027
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.027
|
|
|
|
cell communication by chemical coupling
|
GO:0010643 |
2 |
0.027
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.027
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.027
|
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
0.027
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.027
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.027
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.026
|
|
|
|
positive regulation of plasminogen activation
|
GO:0010756 |
2 |
0.026
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.026
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.026
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.026
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.026
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.026
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.026
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.026
|
|
|
|
response to retinoic acid
|
GO:0032526 |
56 |
0.026
|
|
|
|
regulation of acute inflammatory response
|
GO:0002673 |
27 |
0.026
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.026
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.025
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.025
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.025
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.025
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.025
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.025
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.025
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.025
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.025
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.025
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.025
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
54 |
0.025
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.025
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.025
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.025
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.025
|
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.024
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.024
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.024
|
|
|
|
positive regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014068 |
20 |
0.024
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.024
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
71 |
0.024
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.024
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.024
|
|
|
|
wnt signaling pathway calcium modulating pathway
|
GO:0007223 |
2 |
0.024
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.024
|
|
|
|
non canonical wnt signaling pathway involved in heart development
|
GO:0061341 |
3 |
0.024
|
|
|
|
regulation of phagocytosis
|
GO:0050764 |
33 |
0.024
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.024
|
|
|
|
hepatocyte apoptotic process
|
GO:0097284 |
11 |
0.024
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.024
|
|
|
|
memory
|
GO:0007613 |
58 |
0.024
|
|
|
|
keratinocyte proliferation
|
GO:0043616 |
21 |
0.023
|
|
|
|
inositol lipid mediated signaling
|
GO:0048017 |
41 |
0.023
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.023
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.023
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.023
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.023
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.023
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.023
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.023
|
|
|
|
female meiosis chromosome segregation
|
GO:0016321 |
1 |
0.023
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.023
|
|
|
|
salivary gland development
|
GO:0007431 |
37 |
0.022
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.022
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.022
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.022
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.022
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.022
|
|
|
|
positive regulation of peptide hormone secretion
|
GO:0090277 |
31 |
0.022
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.022
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.022
|
|
|
|
hippocampus development
|
GO:0021766 |
52 |
0.022
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.022
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.022
|
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
45 |
0.022
|
|
|
|
primary alcohol metabolic process
|
GO:0034308 |
11 |
0.022
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.022
|
|
|
|
cell differentiation involved in embryonic placenta development
|
GO:0060706 |
26 |
0.022
|
|
|
|
phosphatidylinositol 3 kinase signaling
|
GO:0014065 |
36 |
0.022
|
|
|
|
cardiac cell fate specification
|
GO:0060912 |
2 |
0.022
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.021
|
|
|
|
endothelial cell differentiation
|
GO:0045446 |
41 |
0.021
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.021
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.021
|
|
|
|
retinol metabolic process
|
GO:0042572 |
9 |
0.021
|
|
|
|
cellular response to tumor necrosis factor
|
GO:0071356 |
21 |
0.021
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.021
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.021
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.021
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.021
|
|
|
|
translation
|
GO:0006412 |
93 |
0.021
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.021
|
|
|
|
phosphatidylinositol mediated signaling
|
GO:0048015 |
41 |
0.021
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.020
|
|
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.020
|
|
|
|
sa node cell to atrial cardiac muscle cell signalling
|
GO:0086018 |
4 |
0.020
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.020
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.020
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.020
|
|
|
|
kinin cascade
|
GO:0002254 |
2 |
0.020
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.020
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.020
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.020
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.020
|
|
|
|
regulation of cardiac muscle contraction
|
GO:0055117 |
21 |
0.020
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.020
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.020
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.020
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.020
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.020
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.020
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.020
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.020
|
|
|
|
white fat cell differentiation
|
GO:0050872 |
15 |
0.020
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.019
|
|
|
|
regulation of blood coagulation
|
GO:0030193 |
28 |
0.019
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.019
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.019
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.019
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.019
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.019
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.019
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.019
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.019
|
|
|
|
chondrocyte development
|
GO:0002063 |
24 |
0.019
|
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
50 |
0.019
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.019
|
|
|
|
renal inner medulla development
|
GO:0072053 |
3 |
0.019
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.019
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.019
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.019
|
|
|
|
positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000081 |
1 |
0.019
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.019
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.019
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.019
|
|
|
|
lens morphogenesis in camera type eye
|
GO:0002089 |
24 |
0.019
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.019
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.019
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.019
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.019
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.019
|
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.019
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.019
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.018
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.018
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.018
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.018
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.018
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.018
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.018
|
|
|
|
regulation of plasminogen activation
|
GO:0010755 |
4 |
0.018
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.018
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.018
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.018
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.018
|
|
|
|
oligopeptide transmembrane transport
|
GO:0035672 |
4 |
0.018
|
|
|
|
positive regulation of peptide secretion
|
GO:0002793 |
33 |
0.018
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.018
|
|
|
|
oxygen homeostasis
|
GO:0032364 |
2 |
0.018
|
|
|
|
fibroblast growth factor production
|
GO:0090269 |
4 |
0.018
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.018
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.018
|
|
|
|
regulation of cardiac muscle cell action potential
|
GO:0098901 |
1 |
0.018
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.018
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.018
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.018
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.018
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.018
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.018
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.018
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.018
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.018
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.018
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.018
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.018
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.017
|
|
|
|
ventricular septum development
|
GO:0003281 |
42 |
0.017
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.017
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.017
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.017
|
|
|
|
regulation of branching involved in salivary gland morphogenesis
|
GO:0060693 |
11 |
0.017
|
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
43 |
0.017
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.017
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.017
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.017
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.017
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.017
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.017
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.017
|
|
